These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
994 related articles for article (PubMed ID: 17114899)
1. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis. Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899 [TBL] [Abstract][Full Text] [Related]
2. DNA fragmentation in acute and chronic rejection after renal transplantation. Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis in progressive crescentic glomerulonephritis. Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789 [TBL] [Abstract][Full Text] [Related]
4. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756 [TBL] [Abstract][Full Text] [Related]
5. A study of apoptosis in human glomerulonephritis as determined by in situ non-radioactive labelling of DNA strand breaks. Wagrowska-Danilewicz M; Danilewicz M Acta Histochem; 1997 Aug; 99(3):257-66. PubMed ID: 9381909 [TBL] [Abstract][Full Text] [Related]
6. The value of proliferating cell nuclear antigen (PCNA)/cyclin in the assessment of cell proliferation in glomerulonephritis. Nakopoulou L; Stefanaki K; Salpigidis K; Boletis J; Papadakis J; Zeiss PM; Vosnides G Histol Histopathol; 1997 Jul; 12(3):655-62. PubMed ID: 9225147 [TBL] [Abstract][Full Text] [Related]
7. Elastase deposits in the kidney and urinary elastase excretion in patients with glomerulonephritis--evidence for neutrophil involvement in renal injury. Kuźniar J; Kuźniar TJ; Marchewka Z; Lembas-Bogaczyk J; Rabczyński J; Kopeć W; Klinger M Scand J Urol Nephrol; 2007; 41(6):527-34. PubMed ID: 17853021 [TBL] [Abstract][Full Text] [Related]
8. Characterization and quantification of proliferating cell patterns in endocapillary proliferation. Wu Q; Tanaka H; Hirukawa T; Endoh M; Fukagawa M Nephrol Dial Transplant; 2012 Aug; 27(8):3234-41. PubMed ID: 22431704 [TBL] [Abstract][Full Text] [Related]
9. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)]. Idasiak-Piechocka I; Krzymański M Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411 [TBL] [Abstract][Full Text] [Related]
10. [Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis]. Ivanova LV; Shilov EM; Ivanov AA; Kozlovskaia LV; Rudolph P; Proppe D Ter Arkh; 2003; 75(6):11-7. PubMed ID: 12920952 [TBL] [Abstract][Full Text] [Related]
11. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Lan HY; Yang N; Nikolic-Paterson DJ; Yu XQ; Mu W; Isbel NM; Metz CN; Bucala R; Atkins RC Kidney Int; 2000 Feb; 57(2):499-509. PubMed ID: 10652026 [TBL] [Abstract][Full Text] [Related]
12. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels. Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632 [TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2 oncoprotein in various types of glomerulonephritis and renal allografts. Nakopoulou L; Stefananki K; Papadakis J; Boletis J; Zeis PM; Kostakis A; Vosnides G Nephrol Dial Transplant; 1996 Jun; 11(6):997-1002. PubMed ID: 8671959 [TBL] [Abstract][Full Text] [Related]
14. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis. Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656 [TBL] [Abstract][Full Text] [Related]
15. Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings. Uğuz A; Gönlüşen G; Ergin M; Tuncer I Nephrology (Carlton); 2005 Jun; 10(3):311-6. PubMed ID: 15958048 [TBL] [Abstract][Full Text] [Related]
16. [Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia]. Shvetsov MIu; Ivanov AA; Kuznetsova AV; Popova OP; Rameeva AS Ter Arkh; 2009; 81(8):14-9. PubMed ID: 19799194 [TBL] [Abstract][Full Text] [Related]
17. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862 [TBL] [Abstract][Full Text] [Related]
18. Tubular proteinuria in IgA glomerulonephritis. Nagy J; Miltényi M; Dobos M; Burger T Clin Nephrol; 1987 Feb; 27(2):76-8. PubMed ID: 3829480 [TBL] [Abstract][Full Text] [Related]
19. Histological changes and immunohistochemical markers in the assessment of glomerulosclerosis in patients with glomerulonephritis. Bob FR; Gluhovschi G; Herman D; Bozdog G; Gluhovschi C; Velciov S; Potencz E; Petrica L Rom J Morphol Embryol; 2011; 52(3 Suppl):1027-32. PubMed ID: 22119820 [TBL] [Abstract][Full Text] [Related]
20. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis. Paydas S; Balal M; Tanriverdi K; Sertdemir Y; Baslamisli F Ren Fail; 2007; 29(7):779-84. PubMed ID: 17994443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]